Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma

Published:2022-04 Issue:2 Volume:114 Page:128-137
ISSN:1591-951X
Container-title:Pathologica
language:
Short-container-title:Pathologica

Author:

Choucair Nader,Saker Zahraa,Kheir Eddine Hassane,Bahmad Hisham F.,Fares Youssef,Zaarour Mariana,Harati Hayat,Nabha Sanaa

Publisher

Siapec Servizi Srl

Subject

Pathology and Forensic Medicine

Reference50 articles.

1. Ricard D, Idbaih A, Ducray F, et al. Primary brain tumours in adults. Lancet 2012;379(9830):1984-1996. https://doi.org/10.1016/s0140-6736(11)61346-9

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. https://doi.org/10.3322/caac.21442

3. Graham CA, Cloughesy TF. Brain tumor treatment: chemotherapy and other new developments. Semin Oncol Nurs 2004;20:260-272.

4. Śledziński P, Zeyland J, Słomski R, et al. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med 2018;7:765-775. https://doi.org/10.1002/cam4.1312

5. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 2012;12:436-444. https://doi.org/10.1038/nrc3247

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of cannabinergics;Cannabis and Khat in Drug Discovery;2024

2. Use of Cannabis and Cannabinoids for Treatment of Cancer;Cancers;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP